Depression and cardiovascular disease: Healing the broken-hearted
Article Abstract:
The importance of major depression in patients with cardiovascular disease is evaluated and practical guidelines are provided for identifying and treating this disorder. It is seen that antidepressant treatment with selective serotonin reuptake inhibitors is generally safe, alleviates depression and improves quality of life and also lessens risk of coronary heart disease and myocardial infarction.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Influence of patients' requests for direct-to-consumer advertised antidepressants
Article Abstract:
A study is conducted to ascertain the effect of patients' direct-to-consumer (DTC)-related requests on physicians' initial treatment decisions in patients with depressive symptoms. The conclusions showed that the patients' request have a profound effect on physician prescribing in major depression and adjustment disorder.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Acute pain treatment
Article Abstract:
The treatment of pain relevant to the medical condition and the different types of pain experienced by patients are presented.
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2008
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Facts: Leprosy. Cardiovascular examination: Part three: Auscultation of the heart. First aid: part 4 - treatment after inhalation of fumes
- Abstracts: Viruses and microRNAs. HIV-1 infection: fooling the gatekeeper. A new entry route for HIV
- Abstracts: Urinary catheter use often "inappropriate" in hospitalized elderly patients. Phase 3 trials suggest ways to improve current hematologic cancer therapies